Heart Failure Therapeutics Market Research: Global Status & Forecast by Geography, Type & Application (2016-2026)

99S3854730
62 Pages
May 2020
Healthcare

Download Sample Get Discount

Summary

According to 99Strategy, the Global Heart Failure Therapeutics Market is estimated to reach xxx million USD in 2020 and projected to grow at the CAGR of xx% during the 2021-2026. The report analyses the global Heart Failure Therapeutics market, the market size and growth, as well as the major market participants.

The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.

Key Regions

Asia Pacific

North America

Europe

South America

Middle East & Africa

Key Companies

Bayer

Cynokinetics

Les Laboratoires Servier

Merck & Co.

Novartis

Procoralan

Bristol-Myers Squibb Company

Cardiorentis AG

CVie Therapeutics Limited

Orion Corporation

PhaseBio Pharmaceuticals

Market Segment by Product Type

B-Blockers

Calcium Channel Blockers

Cardiac Glycosides

Diuretics

Morphine

Vasodilators/Nitrates

Key Product Type

Diagnosis

Prognosis

Treatment Options and Treatment Algorithm

Market by Application

Hospital

Clinic

Medical Research Organization

Main Aspects covered in the Report

Overview of the Heart Failure Therapeutics market including production, consumption, status & forecast and market growth

2016-2020 historical data and 2021-2026 market forecast

Geographical analysis including major countries

Overview the product type market including development

Overview the end-user market including development

Impact of Coronavirus on the Industry

Table of Content

1 Industrial Chain Overview

1.1 Heart Failure Therapeutics Industry

1.1.1 Overview

Figure Heart Failure Therapeutics Picture List

1.1.2 Characteristics of Heart Failure Therapeutics

1.2 Upstream

1.2.1 Major Materials

1.2.2 Manufacturing Overview

1.3 Product List By Type

1.3.1 Diagnosis

1.3.2 Prognosis

1.3.3 Treatment Options and Treatment Algorithm

1.4 End-Use List

1.4.1 Demand in Hospital

1.4.2 Demand in Clinic

1.4.3 Demand in Medical Research Organization

1.5 Global Market Overview

1.5.1 Global Market Size and Forecast, 2016-2026

Figure Global Market Size and Forecast with Growth Rate, 2016-2026

1.5.2 Global Market Size and Forecast by Geography with CAGR, 2016-2026

Table Global Market Size and Forecast by Geography with Growth Rate, 2016-2026

1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2016-2026

Table Global Market Size and Forecast by Type with Growth Rate, 2016-2026

1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2016-2026

Table Global Market Size and Forecast by End-Use with Growth Rate, 2016-2026

2 Global Production & Consumption by Geography

2.1 Global Production & Consumption

2.1.1 Global Production

Figure Global Production Volume Status and Growth Rate, 2016-2020, in Volume

Table Global Production Volume Status and Growth Rate by Geography, 2016-2020, in Volume

Figure Global Production Amount Status and Growth Rate, 2016-2020, in Million USD

Table Global Production Amount Status and Growth Rate by Geography, 2016-2020, in Million USD

2.1.2 Global Consumption

Figure Global Market Volume and Growth Rate, 2016-2020, in Volume

Table Global Market Volume and Growth Rate by Geography, 2016-2020, in Volume

Figure Global Market Amount and Growth Rate, 2016-2020, in Million USD

Table Global Market Amount and Growth Rate by Geography, 2016-2020, in Million USD

2.2 Geographic Production & Consumption

2.2.1 Production

2.2.1.1 Asia-Pacific

Figure Asia-Pacific Production Volume Status and Growth Rate, 2016-2020, in Volume

Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2016-2020, in Volume

Figure Asia-Pacific Production Amount Status and Growth Rate, 2016-2020, in Million USD

Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD

2.2.1.2 North America

Figure North America Production Volume Status and Growth Rate, 2016-2020, in Volume

Table North America Production Volume Status and Growth Rate by Region, 2016-2020, in Volume

Figure North America Production Amount Status and Growth Rate, 2016-2020, in Million USD

Table North America Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD

2.2.1.3 South America

Figure South America Production Volume Status and Growth Rate, 2016-2020, in Volume

Table South America Production Volume Status and Growth Rate by Region, 2016-2020, in Volume

Figure South America Production Amount Status and Growth Rate, 2016-2020, in Million USD

Table South America Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD

2.2.1.4 Europe

Figure Europe Production Volume Status and Growth Rate, 2016-2020, in Volume

Table Europe Production Volume Status and Growth Rate by Region, 2016-2020, in Volume

Figure Europe Production Amount Status and Growth Rate, 2016-2020, in Million USD

Table Europe Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD

2.2.1.5 Middle East & Africa

Figure Middle East & Africa Production Volume Status and Growth Rate, 2016-2020, in Volume

Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2016-2020, in Volume

Figure Middle East & Africa Production Amount Status and Growth Rate, 2016-2020, in Million USD

Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD

2.2.2 Consumption

2.2.2.1 Asia-Pacific

Figure Asia-Pacific Market Volume and Growth Rate, 2016-2020, in Volume

Table Asia-Pacific Market Volume and Growth Rate by Region, 2016-2020, in Volume

Figure Asia-Pacific Market Amount and Growth Rate, 2016-2020, in Million USD

Table Asia-Pacific Market Amount and Growth Rate by Region, 2016-2020, in Million USD

2.2.2.2 North America

Figure North America Market Volume and Growth Rate, 2016-2020, in Volume

Table North America Market Volume and Growth Rate by Region, 2016-2020, in Volume

Figure North America Market Amount and Growth Rate, 2016-2020, in Million USD

Table North America Market Amount and Growth Rate by Region, 2016-2020, in Million USD

2.2.2.3 South America

Figure South America Market Volume and Growth Rate, 2016-2020, in Volume

Table South America Market Volume and Growth Rate by Region, 2016-2020, in Volume

Figure South America Market Amount and Growth Rate, 2016-2020, in Million USD

Table South America Market Amount and Growth Rate by Region, 2016-2020, in Million USD

2.2.2.4 Europe

Figure Europe Market Volume and Growth Rate, 2016-2020, in Volume

Table Europe Market Volume and Growth Rate by Region, 2016-2020, in Volume

Figure Europe Market Amount and Growth Rate, 2016-2020, in Million USD

Table Europe Market Amount and Growth Rate by Region, 2016-2020, in Million USD

2.2.2.5 Middle East & Africa

Figure Middle East & Africa Market Volume and Growth Rate, 2016-2020, in Volume

Table Middle East & Africa Market Volume and Growth Rate by Region, 2016-2020, in Volume

Figure Middle East & Africa Market Amount and Growth Rate, 2016-2020, in Million USD

Table Middle East & Africa Market Amount and Growth Rate by Region, 2016-2020, in Million USD

3 Major Manufacturers Introduction

3.1 Manufacturers Overview

Table Major Manufacturers Headquarters and Contact Information

Table Major Manufacturers Capacity List in 2018

3.2 Manufacturers List

3.2.1 Bayer Overview

Table Bayer Overview List

3.2.1.1 Product Specifications

3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Heart Failure Therapeutics Business Operation of Bayer (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.1.3 Recent Developments

3.2.1.4 Future Strategic Planning

3.2.2 Cynokinetics Overview

Table Cynokinetics Overview List

3.2.2.1 Product Specifications

3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Heart Failure Therapeutics Business Operation of Cynokinetics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.2.3 Recent Developments

3.2.2.4 Future Strategic Planning

3.2.3 Les Laboratoires Servier Overview

Table Les Laboratoires Servier Overview List

3.2.3.1 Product Specifications

3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Heart Failure Therapeutics Business Operation of Les Laboratoires Servier (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.3.3 Recent Developments

3.2.3.4 Future Strategic Planning

3.2.4 Merck & Co. Overview

Table Merck & Co. Overview List

3.2.4.1 Product Specifications

3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Heart Failure Therapeutics Business Operation of Merck & Co. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.4.3 Recent Developments

3.2.4.4 Future Strategic Planning

3.2.5 Novartis Overview

Table Novartis Overview List

3.2.5.1 Product Specifications

3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Heart Failure Therapeutics Business Operation of Novartis (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.5.3 Recent Developments

3.2.5.4 Future Strategic Planning

3.2.6 Procoralan Overview

Table Procoralan Overview List

3.2.6.1 Product Specifications

3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Heart Failure Therapeutics Business Operation of Procoralan (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.6.3 Recent Developments

3.2.6.4 Future Strategic Planning

3.2.7 Bristol-Myers Squibb Company Overview

Table Bristol-Myers Squibb Company Overview List

3.2.7.1 Product Specifications

3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Heart Failure Therapeutics Business Operation of Bristol-Myers Squibb Company (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.7.3 Recent Developments

3.2.7.4 Future Strategic Planning

3.2.8 Cardiorentis AG Overview

Table Cardiorentis AG Overview List

3.2.8.1 Product Specifications

3.2.8.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Heart Failure Therapeutics Business Operation of Cardiorentis AG (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.8.3 Recent Developments

3.2.8.4 Future Strategic Planning

3.2.9 CVie Therapeutics Limited Overview

Table CVie Therapeutics Limited Overview List

3.2.9.1 Product Specifications

3.2.9.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Heart Failure Therapeutics Business Operation of CVie Therapeutics Limited (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.9.3 Recent Developments

3.2.9.4 Future Strategic Planning

3.2.10 Orion Corporation Overview

Table Orion Corporation Overview List

3.2.10.1 Product Specifications

3.2.10.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Heart Failure Therapeutics Business Operation of Orion Corporation (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.10.3 Recent Developments

3.2.10.4 Future Strategic Planning

3.2.11 PhaseBio Pharmaceuticals Overview

Table PhaseBio Pharmaceuticals Overview List

3.2.11.1 Product Specifications

3.2.11.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Heart Failure Therapeutics Business Operation of PhaseBio Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.11.3 Recent Developments

3.2.11.4 Future Strategic Planning

3.2.12 Market Segment by Product Type Overview

Table Market Segment by Product Type Overview List

3.2.12.1 Product Specifications

3.2.12.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Heart Failure Therapeutics Business Operation of Market Segment by Product Type (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.12.3 Recent Developments

3.2.12.4 Future Strategic Planning

3.2.13 B-Blockers Overview

Table B-Blockers Overview List

3.2.13.1 Product Specifications

3.2.13.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Heart Failure Therapeutics Business Operation of B-Blockers (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.13.3 Recent Developments

3.2.13.4 Future Strategic Planning

3.2.14 Calcium Channel Blockers Overview

Table Calcium Channel Blockers Overview List

3.2.14.1 Product Specifications

3.2.14.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Heart Failure Therapeutics Business Operation of Calcium Channel Blockers (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.14.3 Recent Developments

3.2.14.4 Future Strategic Planning

3.2.15 Cardiac Glycosides Overview

Table Cardiac Glycosides Overview List

3.2.15.1 Product Specifications

3.2.15.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Heart Failure Therapeutics Business Operation of Cardiac Glycosides (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.15.3 Recent Developments

3.2.15.4 Future Strategic Planning

3.2.16 Diuretics Overview

Table Diuretics Overview List

3.2.16.1 Product Specifications

3.2.16.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Heart Failure Therapeutics Business Operation of Diuretics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.16.3 Recent Developments

3.2.16.4 Future Strategic Planning

3.2.17 Morphine Overview

Table Morphine Overview List

3.2.17.1 Product Specifications

3.2.17.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Heart Failure Therapeutics Business Operation of Morphine (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.17.3 Recent Developments

3.2.17.4 Future Strategic Planning

3.2.18 Vasodilators/Nitrates Overview

Table Vasodilators/Nitrates Overview List

3.2.18.1 Product Specifications

3.2.18.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Heart Failure Therapeutics Business Operation of Vasodilators/Nitrates (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.18.3 Recent Developments

3.2.18.4 Future Strategic Planning

4 Market Competition Pattern

4.1 Market Size and Sketch

Figure Global Market Size and Growth Rate, 2016-2020, in Volume

Figure Global Market Size and Growth Rate, 2016-2020, in Million USD

Figure Global Competition Sketch Overview

4.2 Company Market Share

4.2.1 Global Production by Major Manufacturers

Table Global Production Volume List by Manufacturers, 2016-2020, in Volume

Table Global Production Volume Share List by Manufacturers, 2016-2020, in Volume

Figure Global Production Volume Share by Manufacturers in 2020, in Volume

Table Global Production Amount List by Manufacturers, 2016-2020, in Million USD

Table Global Production Amount Share List by Manufacturers, 2016-2020, in Million USD

Figure Global Production Amount Share by Manufacturers in 2020, in Million USD

4.2.2 Market Concentration Analysis

4.3 Market News and Trend

4.3.1 Merger & Acquisition

4.3.2 New Product Launch

5 Product Type Segment

5.1 Global Overview by Product Type Segment

Table Global Market Status and Growth Rate by Product Type Segment, 2016-2020, in Million USD

Table Global Market Status and Growth Rate by Product Type Segment 2016-2020, in Volume

5.2 Segment Subdivision by Product Type

5.2.1 Market in Diagnosis

5.2.1.1 Market Size

Figure Global Market Amount and Growth Rate in Diagnosis, 2016-2020, in USD Million

Figure Global Market Amount and Growth Rate in Diagnosis, 2016-2020, in Volume

5.2.1.2 Situation & Development

5.2.2 Market in Prognosis

5.2.2.1 Market Size

Figure Global Market Amount and Growth Rate in Prognosis, 2016-2020, in USD Million

Figure Global Market Amount and Growth Rate in Prognosis, 2016-2020, in Volume

5.2.2.2 Situation & Development

5.2.3 Market in Treatment Options and Treatment Algorithm

5.2.3.1 Market Size

Figure Global Market Amount and Growth Rate in Treatment Options and Treatment Algorithm, 2016-2020, in USD Million

Figure Global Market Amount and Growth Rate in Treatment Options and Treatment Algorithm, 2016-2020, in Volume

5.2.3.2 Situation & Development

6 End-Use Segment

6.1 Global Overview by End-Use Segment

Table Global Market Status and Growth Rate by End-Use Segment, 2016-2020, in Million USD

Table Global Market Status and Growth Rate by End-Use Segment 2016-2020, in Volume

6.2 Segment Subdivision

6.2.1 Market in Hospital

6.2.1.1 Market Size

Figure Global Market Amount and Growth Rate in Hospital, 2016-2020, in USD Million

Figure Global Market Amount and Growth Rate in Hospital, 2016-2020, in Volume

6.2.1.2 Situation & Development

6.2.2 Market in Clinic

6.2.2.1 Market Size

Figure Global Market Amount and Growth Rate in Clinic, 2016-2020, in USD Million

Figure Global Market Amount and Growth Rate in Clinic, 2016-2020, in Volume

6.2.2.2 Situation & Development

6.2.3 Market in Medical Research Organization

6.2.3.1 Market Size

Figure Global Market Amount and Growth Rate in Medical Research Organization, 2016-2020, in USD Million

Figure Global Market Amount and Growth Rate in Medical Research Organization, 2016-2020, in Volume

6.2.3.2 Situation & Development

7 Market Forecast & Trend

7.1 Regional Forecast

Table Global Market Forecast by Region Segment 2021-2026, in Million USD

Table Global Market Forecast by Region Segment 2021-2026, in Volume

7.2 Consumption Forecast

7.2.1 Product Type Forecast

Table Global Market Amount by Product Type Segment 2021-2026, in Million USD

Table Global Market Volume by Product Type Segment 2021-2026, in Volume

7.2.2 End-Use Forecast

Table Global Market Amount by End-Use Segment 2021-2026, in Million USD

Table Global Market Volume by End-Use Segment 2021-2026, in Volume

7.3 Investment Trend

7.4 Consumption Trend

8 Price & Channel

8.1 Price and Cost

8.1.1 Price

8.1.2 Cost

Figure Cost Component Ratio

8.2 Channel Segment

9 Market Drivers & Investment Environment

9.1 Market Drivers

9.2 Investment Environment

9.3 Impact of Coronavirus on the Heart Failure Therapeutics Industry

9.3.1 Impact on Industry Upstream

9.3.2 Impact on Industry Downstream

9.3.3 Impact on Industry Channels

9.3.4 Impact on Industry Competition

9.3.5 Impact on Industry Employment

10 Research Conclusion

List of Table